Update on McKesson US distribution agreement for DiaSpect Tm

 22nd Jan 2019

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that further to the private label distribution agreement with McKesson Medical-Surgical Inc., sales of the McKesson Consult® Hb analyzer are expected next month following the full launch of the product in the US.

 

In August 2018 EKF signed a private label distribution agreement with McKesson Medical-Surgical Inc., an affiliate of the McKesson Corporation, for the Company’s hand-held reagent-free hemoglobin analyzer, the DiaSpect Tm. McKesson is the oldest and largest healthcare company in the US, serving more than 50% of US hospitals and 20% of physicians. The DiaSpect Tm is the world’s fastest hemoglobin analyzer and will be sold in the US by McKesson under its own branded line, as the McKesson Consult® Hb analyzer.

 

The agreement follows US Food and Drug Administration 510(k) clearance and CLIA waiver by statute for the DiaSpect Tm in April 2018, approving the product for use in point of care and Certificate of Waiver settings. 

 

The full launch of the McKesson Consult® Hb analyzer in the US is scheduled for 6 February 2019 with sales contributing to EKF revenue growth in the current financial year ending 31 December 2019 and onwards.

 

For more information on the DiaSpect Tm see: www.ekfdiagnostics.com/diaspect.html 

 

Commenting, Julian Baines, CEO of EKF Diagnostics, said: The DiaSpect Tm gives physicians access to an easy to use, accurate and portable hemoglobin measurement system able to deliver laboratory quality results at the point of care within seconds. This agreement with McKesson allows us to offer our innovative point of care hemoglobin analysis technology to physicians and childcare specialists across the US through the market’s leading and most established healthcare distribution player. It also affirms the quality of EKF’s product and manufacturing capabilities.”

 

Christopher Rogers, Vice President, McKesson Brands: “We are excited to partner with EKF Diagnostics to offer this industry leading technology, providing physicians a convenient design and fast, accurate results for onsite blood testing. The McKesson Consult® Hb analyzer demonstrates McKesson Brands’ ongoing commitment to offering value-oriented lab solutions to assist our customers in providing improved care for their patients.”

 

Enquiries:

EKF Diagnostics Holdings plc
Christopher Mills, Non-Executive Chairman
Julian Baines, CEO
Richard Evans, Finance Director and COO

www.ekfdiagnostics.com
Tel: 00 44 29 2071 0570
N+1 Singer (Nomad & Broker)

Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)
Tel: 020 7496 3000

Walbrook PR Limited
Paul McManus
Lianne Cawthorne

Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303